WILMINGTON, DE: AstraZeneca is using social media for the first time to recruit patients for a nationwide clinical trial.
The Phase III trial seeks to determine whether an investigational drug is safe and effective for patients suffering from opiod-induced constipation.
Dealing with a competitive clinical trial market, the pharmaceutical company believes that social media channels will provide an effective communications path due to the increasing numbers of consumers who turn to the Internet for health information.
“This seemed like another tool in our toolbox,” said Anna ...